Home/Libera Bio/Desirée Teijeiro Osorio
DT

Desirée Teijeiro Osorio

COO

Libera Bio

Therapeutic Areas

Libera Bio Pipeline

DrugIndicationPhase
Undisclosed (Platform-derived)Oncology (e.g., KRAS-mutant cancers)Pre-clinical